The EstLat project „Development of Positron Emission Tomography (PET) precursor“ is funded under the “active and attractive business environment” priority with a specific objective of more jointly-developed products and services in the programme area in amount of 480 754,52 €.
The Project implemented in cooperation with Latvian company Pharmidea SIA. The main objective of the Project is to develop a PET-product used in Positron emission tomography-computer tomography (PET-CT) for cancer, Alzheimer or Parkinson diagnostics.
The Estonia-Latvia programme is one of the 60 cross-border cooperation programmes operating along EU internal borders. The programme is funded under the goal of the European Territorial Cooperation, better known as Interreg and aims at strengthening cooperation among regions across the borders of Estonia and Latvia. 35 million euros are made available by the European Regional Development Fund for funding cooperation projects among Estonian and Latvian partner organizations.
This website reflects the views of the author. The managing authority of the programme is not liable for how this information may be used.